Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...

Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...